Phase 1 study of FOY-305(FOY-305-02)(COVID-19)

Authors
Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2020
This article has no abstract
Epistemonikos ID: 1d310d028473b47ca780543e64b95a2042377e61
First added on: Jul 15, 2020